• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜联蛋白-1下调与中国肝门部胆管癌患者的临床预后相关。

Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma.

作者信息

Wang D, Zhang H, Fang Z, Yu G

机构信息

Department of General Surgery, Affiliated Hospital of Qingdao University Medical College, Qingdao, PR China.

出版信息

Eur Surg Res. 2010;45(3-4):151-7. doi: 10.1159/000320237. Epub 2010 Oct 6.

DOI:10.1159/000320237
PMID:20924191
Abstract

AIMS

Annexin A1 (ANXA1) is a calcium- and phospholipid-binding protein and has been implicated in regulating inflammatory responses, cell proliferation and apoptosis. The evidence of its importance in carcinogenesis increased rapidly. However, the status of ANXA1 in hilar cholangiocarcinoma remains unclear. Here, we detected ANXA1 expression and determined its clinical significance in Chinese patients with hilar cholangiocarcinoma.

METHODS

Tissue microarray blocks containing tumor specimens obtained from 61 patients were constructed. Expression of ANXA1 in these specimens was analyzed using immunohistochemical studies.

RESULTS

ANXA1 expression was observed in 27 cases (44.3%). Loss of ANXA1 expression was significantly associated with lymph node metastases and histopathologic grade. ANXA1 expression has a significant inverse correlation with recurrence and poor survival in univariate analyses.Multivariate analyses revealed that loss of ANXA1 expression was an independent predictor for future recurrence and overall survival in patients with cholangiocarcinoma.

CONCLUSIONS

Decreased expression of ANXA1 is a common event in human hilar cholangiocarcinoma and is significantly correlated with the poor outcome of patients with cholangiocarcinoma, suggesting a potential role of ANXA1 in cancer development and progression.

摘要

目的

膜联蛋白A1(ANXA1)是一种钙和磷脂结合蛋白,与调节炎症反应、细胞增殖和凋亡有关。其在致癌过程中的重要性证据迅速增加。然而,ANXA1在肝门部胆管癌中的状态仍不清楚。在此,我们检测了中国肝门部胆管癌患者中ANXA1的表达,并确定了其临床意义。

方法

构建包含61例患者肿瘤标本的组织芯片块。使用免疫组织化学研究分析这些标本中ANXA1的表达。

结果

27例(44.3%)观察到ANXA1表达。ANXA1表达缺失与淋巴结转移和组织病理学分级显著相关。在单因素分析中,ANXA1表达与复发和不良生存呈显著负相关。多因素分析显示,ANXA1表达缺失是胆管癌患者未来复发和总生存的独立预测因素。

结论

ANXA1表达降低在人类肝门部胆管癌中是常见事件,且与胆管癌患者的不良预后显著相关,提示ANXA1在癌症发生和发展中具有潜在作用。

相似文献

1
Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma.膜联蛋白-1下调与中国肝门部胆管癌患者的临床预后相关。
Eur Surg Res. 2010;45(3-4):151-7. doi: 10.1159/000320237. Epub 2010 Oct 6.
2
Annexin A1: A new immunohistological marker of cholangiocarcinoma.膜联蛋白 A1:胆管癌的一种新的免疫组织化学标志物。
World J Gastroenterol. 2013 Apr 28;19(16):2456-65. doi: 10.3748/wjg.v19.i16.2456.
3
Overexpression of ATA1/SLC38A1 predicts future recurrence and death in Chinese patients with hilar cholangiocarcinoma.ATA1/SLC38A1 过表达可预测中国肝门部胆管癌患者的未来复发和死亡。
J Surg Res. 2011 Dec;171(2):663-8. doi: 10.1016/j.jss.2010.03.049. Epub 2010 Apr 18.
4
Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.膜联蛋白 A1 是胆管癌的一个潜在预后标志物,并增强其转移能力。
Asian Pac J Cancer Prev. 2022 Feb 1;23(2):715-721. doi: 10.31557/APJCP.2022.23.2.715.
5
Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.沉默 CXCR4 抑制人肝门部胆管癌细胞增殖和神经侵袭。
Gut Liver. 2014 Mar;8(2):196-204. doi: 10.5009/gnl.2014.8.2.196. Epub 2013 Nov 5.
6
Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.淋巴结微转移与其他方面淋巴结阴性的肝门部胆管癌患者较差的生存率相关。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1107-15. doi: 10.1245/s10434-015-4723-9. Epub 2015 Jul 16.
7
Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma.磷酸化4E结合蛋白1的过表达预示着中国肝门部胆管癌患者的淋巴结转移及不良预后。
Med Oncol. 2014 May;31(5):940. doi: 10.1007/s12032-014-0940-5. Epub 2014 Apr 6.
8
Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.MTSS1 表达缺失是肝内胆管细胞癌的一个独立预后因素。
Pathol Oncol Res. 2013 Oct;19(4):815-20. doi: 10.1007/s12253-013-9649-6. Epub 2013 Jul 14.
9
Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer.组织芯片分析揭示了有力的临床证据,表明膜联蛋白A1表达缺失与胃癌淋巴结转移之间存在密切关联。
Clin Exp Metastasis. 2008;25(7):695-702. doi: 10.1007/s10585-008-9178-y. Epub 2008 Jun 6.
10
TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma.TROP2 与肝门部胆管癌的微血管密度和不良预后相关。
J Gastrointest Surg. 2013 Feb;17(2):360-8. doi: 10.1007/s11605-012-2105-1. Epub 2012 Dec 1.

引用本文的文献

1
Pathobiological functions and clinical implications of annexin dysregulation in human cancers.膜联蛋白失调在人类癌症中的病理生物学功能及临床意义
Front Cell Dev Biol. 2022 Sep 28;10:1009908. doi: 10.3389/fcell.2022.1009908. eCollection 2022.
2
Annexin Expression in Cholangiocarcinoma, and Metastatic Pancreatic Ductal Adenocarcinoma "Is it be Helpful for Differential Diagnosis of These Tumors in the Liver?".膜联蛋白在胆管癌及转移性胰腺导管腺癌中的表达:“其对肝脏中这些肿瘤的鉴别诊断是否有帮助?”
Iran J Pathol. 2021 Fall;16(4):433-438. doi: 10.30699/IJP.20201.138489.2512. Epub 2021 Jul 6.
3
FOXK1 plays an oncogenic role in the progression of hilar cholangiocarcinoma.
FOXK1 在肝门部胆管癌的进展中发挥致癌作用。
Mol Med Rep. 2021 Feb;23(2). doi: 10.3892/mmr.2020.11730. Epub 2020 Dec 10.
4
Advancements of Annexin A1 in inflammation and tumorigenesis.膜联蛋白A1在炎症和肿瘤发生中的研究进展。
Onco Targets Ther. 2019 Apr 30;12:3245-3254. doi: 10.2147/OTT.S202271. eCollection 2019.
5
SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.SPARCL1是肝门部胆管癌肿瘤复发和生存的一种新型预测指标。
Tumour Biol. 2016 Mar;37(3):4159-67. doi: 10.1007/s13277-015-4206-4. Epub 2015 Oct 21.
6
Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma.Sig1R的过表达与肝门部胆管癌患者的肿瘤进展及不良预后密切相关。
Med Oncol. 2014 Dec;31(12):261. doi: 10.1007/s12032-014-0261-8. Epub 2014 Oct 26.
7
Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers.膜联蛋白A1(ANXA1)在人胃肠道良性组织和癌症中的差异表达。
BMC Cancer. 2014 Jul 19;14:520. doi: 10.1186/1471-2407-14-520.
8
Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma.细胞核膜联蛋白A1与食管鳞状细胞癌患者预后的相关性
Int J Clin Exp Pathol. 2014 Jan 15;7(2):751-9. eCollection 2014.
9
Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.MTSS1 表达缺失是肝内胆管细胞癌的一个独立预后因素。
Pathol Oncol Res. 2013 Oct;19(4):815-20. doi: 10.1007/s12253-013-9649-6. Epub 2013 Jul 14.
10
Annexin A1: A new immunohistological marker of cholangiocarcinoma.膜联蛋白 A1:胆管癌的一种新的免疫组织化学标志物。
World J Gastroenterol. 2013 Apr 28;19(16):2456-65. doi: 10.3748/wjg.v19.i16.2456.